Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$4.65 USD
-0.30 (-6.06%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $4.64 -0.01 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (84 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.37 | 9.99 |
Current Quarter Estimate | -0.18 | 3.10 | 61.00 |
Year Ago Quarter Estimate | 0.00 | -4.81 | 54.84 |
Next Quarter Estimate | -0.18 | 3.85 | 63.00 |
Next Year Estimate | -0.58 | 24.86 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1,325.00 | 17.20 | 15.67 |
Next Year | -18.37 | 9.40 | 11.34 |
Last 5 Years | -45.60 | 0.90 | 8.10 |
Next 5 Years | NA | 22.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.44 |
Price/Book (MRQ) | 0.53 | 2.10 |
Price/Cash Flow (MRFY) | NA | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -6.00% | -150.51% |
Return on Equity (TTM) | -2.01% | -61.16% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.